These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29249238)

  • 1. Identification of nonstandard macrocyclic peptide ligands through display screening.
    Taylor RD; Rey-Carrizo M; Passioura T; Suga H
    Drug Discov Today Technol; 2017 Dec; 26():17-23. PubMed ID: 29249238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Display Selection of Exotic Macrocyclic Peptides Expressed under a Radically Reprogrammed 23 Amino Acid Genetic Code.
    Passioura T; Liu W; Dunkelmann D; Higuchi T; Suga H
    J Am Chem Soc; 2018 Sep; 140(37):11551-11555. PubMed ID: 30157372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides.
    Goto Y; Suga H
    Acc Chem Res; 2021 Sep; 54(18):3604-3617. PubMed ID: 34505781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Selection of Thioether-Closed Macrocyclic Peptide Ligands by Means of the RaPID System.
    Katoh T; Goto Y; Suga H
    Methods Mol Biol; 2022; 2371():247-259. PubMed ID: 34596852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro genetic code reprogramming and expansion to study protein function and discover macrocyclic peptide ligands.
    Richardson SL; Dods KK; Abrigo NA; Iqbal ES; Hartman MC
    Curr Opin Chem Biol; 2018 Oct; 46():172-179. PubMed ID: 30077877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide Display Technologies.
    Pitt A; Nims Z
    Methods Mol Biol; 2019; 2001():285-298. PubMed ID: 31134576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthetic Strategies for Macrocyclic Peptides.
    Wang W; Khojasteh SC; Su D
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34206124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells.
    Kawakami T; Ishizawa T; Fujino T; Reid PC; Suga H; Murakami H
    ACS Chem Biol; 2013; 8(6):1205-14. PubMed ID: 23517428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of De Novo Macrocyclic Peptides by Messenger RNA Display.
    Peacock H; Suga H
    Trends Pharmacol Sci; 2021 May; 42(5):385-397. PubMed ID: 33771353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection-based discovery of druglike macrocyclic peptides.
    Passioura T; Katoh T; Goto Y; Suga H
    Annu Rev Biochem; 2014; 83():727-52. PubMed ID: 24580641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes.
    Saha A; Suga H; Brik A
    Acc Chem Res; 2023 Jul; 56(14):1953-1965. PubMed ID: 37312234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies.
    Bashiruddin NK; Suga H
    Curr Opin Chem Biol; 2015 Feb; 24():131-8. PubMed ID: 25483262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets.
    Passioura T; Suga H
    Chem Commun (Camb); 2017 Feb; 53(12):1931-1940. PubMed ID: 28091672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring sequence space: harnessing chemical and biological diversity towards new peptide leads.
    Obexer R; Walport LJ; Suga H
    Curr Opin Chem Biol; 2017 Jun; 38():52-61. PubMed ID: 28319812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologies for Backbone Macrocyclic Peptide Synthesis Compatible With Screening Technologies.
    Shinbara K; Liu W; van Neer RHP; Katoh T; Suga H
    Front Chem; 2020; 8():447. PubMed ID: 32626683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomal Synthesis of Macrocyclic Peptides with β
    Adaligil E; Song A; Hallenbeck KK; Cunningham CN; Fairbrother WJ
    ACS Chem Biol; 2021 Jun; 16(6):1011-1018. PubMed ID: 34008946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library.
    Yamagishi Y; Shoji I; Miyagawa S; Kawakami T; Katoh T; Goto Y; Suga H
    Chem Biol; 2011 Dec; 18(12):1562-70. PubMed ID: 22195558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technologies for the synthesis of mRNA-encoding libraries and discovery of bioactive natural product-inspired non-traditional macrocyclic peptides.
    Ito K; Passioura T; Suga H
    Molecules; 2013 Mar; 18(3):3502-28. PubMed ID: 23507778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA Display Methods for the Discovery of Bioactive Macrocycles.
    Huang Y; Wiedmann MM; Suga H
    Chem Rev; 2019 Sep; 119(17):10360-10391. PubMed ID: 30395448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexizymes as a tRNA acylation tool facilitating genetic code reprogramming.
    Goto Y; Suga H
    Methods Mol Biol; 2012; 848():465-78. PubMed ID: 22315087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.